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Abstract 26 
We report on the diagnostic sensitivity of 3 EU-approved rapid tests (1 from IDEXX and 2 27 
from BIO-RAD) for the detection of transmissible spongiform encephalopathy (TSE) diseases 28 
in goats. Ninety-eight goat brain stem samples were tested. All of rapid tests had 100% 29 
specificity and ≥80% sensitivity with the IDEXX test significantly more sensitive than the 2 30 
Bio-Rad tests. All tests detected 100% of samples from goats with clinical scrapie, but missed 31 
between 7% (IDEXX) and 24% (BIORAD-SG) of samples from pre-clinical goats. 32 
Importantly, only IDEXX picked up all samples from clinical BSE-infected goats, whereas 33 
the other 2 rapid tests missed between 15% (BIORAD-SG) and 25% (BIORAD-SAP). These 34 
results show that a fraction of pre-clinical scrapie infections are likely missed by the EU 35 
surveillance, with sensitivity of detection strongly depending on the choice of the rapid test. 36 
Moreover, a significant proportion of clinical BSE infections are underestimated by using 37 
either BIO-RAD test. Assuming that the same sensitivity on pre-clinical goats would also 38 
occur in BSE-infected goats, our data suggest that IDEXX is likely the most sensitive test for 39 
detecting preclinical field cases of BSE infection in goats, though with a 7% failure rate. 40 
These results raise some concerns about the reliability of current EU surveillance figures on 41 
BSE infection in goats. 42 
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Prion infection induces progressive and untreatable neurodegenerative diseases in humans, 45 
wild and farmed ruminants, and occasionally in other mammalian species. Prion or 46 
transmissible spongiform encephalopathy (TSE) diseases are characterized by the formation 47 
and accumulation of an abnormal isoform of the natural prion protein (PrPc) in the central 48 
nervous system (CNS) and, occasionally, in peripheral tissues. The pathological prion protein 49 
(PrPSc) differs from PrPc because it appears refolded, aggregated and partially protease 50 
resistant. These unique features of PrPSc have been used for the development of most 51 
diagnostic methods currently used for the detection of TSE diseases.  52 
Scrapie disease of sheep and goats has been endemic in Europe for ≥200 years, but has never 53 
been convincingly associated with any form of human TSE disease, although recent data 54 
based on experimental transmission of scrapie to humanized mice4 or non-human primates7 55 
have re-opened this issue. On the other hand, the epidemic of bovine spongiform 56 
encephalopathy (BSE) in the UK and other European cattle populations has been 57 
unequivocally linked to the appearance of variant Creutzfeldt-Jakob disease in humans2,23,5. 58 
Because BSE is experimentally transmissible to sheep and goats10 and these small ruminants 59 
were likely exposed to BSE-contaminated feed in the early 1980s, there is concern that the 60 
BSE agent may circulate in the sheep and goat population representing a possible secondary 61 
risk to humans8,11. 62 
In 2006 the Commission Regulation (EC) 253/20066 approved 9 rapid postmortem tests to 63 
monitor the prevalence of scrapie and BSE in small ruminant populations. Sensitivity, based 64 
on the lowest detectable concentration of PrPSc above background noise, and specificity were 65 
assessed in classical scrapie cases. In addition, the performance of these tests for the 66 
identification of atypical scrapie and BSE in sheep was also evaluated20,21,18,17,19.  In the frame 67 
of such evaluations, only IDEXXa, BIORAD-SAPb and BIORAD-SGc tests were able to 68 
detect atypical scrapie, a result also confirmed by routine screening for scrapie in sheep and 69 
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goats3, 22.  In 2012, EFSA also recommended PrioSTRIP SRd test (visual reading protocol) for 70 
the detection of TSE disease in small ruminants. However, a specific study on the suitability 71 
of rapid methods for the detection of TSE diseases in goats was never performed. 72 
The goat population in Europe is considerably smaller than that of sheep one, but these 73 
ruminants were likely highly exposed to the BSE agent because of feeding of concentrate for 74 
dairy farming purposes. Thus, evaluation of surveillance system in place for the goat 75 
population is crucial.  76 
We compared the performance of 3 EU-approved rapid postmortem tests for active 77 
surveillance of TSE diseases on brain samples from goats with ‘natural’ scrapie or goats with 78 
experimental scrapie or BSE. These three rapid tests resulted 100% specific and sensitive for 79 
detecting TSE diseases in sheep. 80 
Ninety-eight goat brain stem samples were included in the study. All samples were prepared 81 
as 50% tissue macerates in water as below. Thirty-one of these samples were sourced from 82 
goats with ‘natural’ scrapie from seven different EU countries (Table 1), 7 from clinically 83 
affected goats and 24 from clinically healthy animals. Other samples (n=32) from goats with 84 
experimentally induced scrapie or BSE were provided by the CVI, FLI, Roslin, INRA and 85 
CEA (full names in Table 1). All samples from TSE positive animals resulted also PrPSc 86 
positive at western blot or immunohistochemical analyses as required by the EU Regulation 87 
(EC) N. 999/20019. PRNP analyses revealed that 60% of goats carried the wild genotype, 88 
while in a few animals polymorphisms I142M (11%), H143R (9%), R154H (2%), R211Q 89 
(23%) or repeats deletion (4%) were found in a few animals. Negative control samples were 90 
from clinically healthy goats slaughtered in Italy and they were, as expected, negative by 91 
Western blot analysis14. The whole brain stem sample tissue was trimmed, pooled, mildly 92 
minced with a scalpel blade, until the tissue appeared homogeneous. Sterile nuclease-free 93 
water was added in an equal amount (50% water/volume) to create a 1:1 dilution. The 94 
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suspension was subjected to cycles of homogenization using a low-speed hand-held 95 
homogenizing unit until achievement of a homogeneous paste. The resulting homogenate was 96 
immediately stored at -80°C and kept frozen until tested. Samples were tested by the IDEXX, 97 
the BIORAD-SAP, and the BIORAD-SG ELISAs tests according to the manufacturer’s test 98 
instructions. The PrioSTRIP SR test was not included in this analysis. The 3 tests are based 99 
on semi-quantitative ELISA methods that produce a qualitative result relative to a cut-off 100 
value. The two BIORAD tests include a PK digestion step to unmask cryptic epitopes, 101 
whereas the IDEXX test relies on conformational detection technology using a specific 102 
proteinase resistant binding dextran polymer12.  103 
The manufacturers specifically provided a unique batch of each rapid test well before the 104 
expiry dates to avoid false results producted by old, though still unexpired batches. Samples 105 
were coded and then tested in duplicate except for 3 samples from Greece and 1 from the UK 106 
because of insufficiently available material. The 3 rapid tests use semi-quantitative ELISA 107 
methods that produce qualitative results based on cut-off values. Samples with optical density 108 
lower than the cut-off value on both replicates were considered negative. Samples showing an 109 
optical density greater than or equal to the cut-off value at least on one replicate were 110 
considered positive. However, because the Bio-Rad specifications suggest a cautious 111 
interpretation of samples situated just below the cut-off value (cut-off value - 10%), we 112 
arbitrarily chose to consider these samples as positive. Environmental conditions that might 113 
influence testing, such as temperature and humidity, were strictly controlled and monitored 114 
during analytical sessions. 115 
The efficiency of each rapid test was assessed by the receiver operating characteristic (ROC) 116 
curve analyses (STATA 11, StataCorp LP). Nonparametric ROC curves analyzed TSE-117 
infected goats vs healthy and unaffected goats. The area under the ROC curve (AUC) and its 118 
95% confidence interval (95% CI) indicate diagnostic efficiency. 119 
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Overall, the 3 EU-approved rapid tests analyzed showed 100% specificity and >80% 120 
sensitivity (Table 2). However, ROC curves showed that the IDEXX test was significantly 121 
more sensitive (97%) than the 2 BIORAD rapid tests (Table 3, 4; Figure 1A), which showed 122 
sensitivity just >80%.  123 
A more detailed analysis showed that all three rapid tests recognized 100% of samples from 124 
goats with experimental scrapie regardless of the route of infection, but only IDEXX showed 125 
100% sensitivity in detecting BSE-infected goats (Table 2, 4). The other 2 rapid tests missed 126 
3 (BIORAD-SG) to 5 (BIORAD-SAP) of the 20 BSE samples (Table 2) with differences that 127 
reached significance only between IDEXX and BIORAD-SAP tests (Table 4, Figure 1C).  128 
In goats with natural ‘classical’ scrapie, the IDEXX test missed 2 of 29 samples and none of 129 
the ‘atypical’ scrapie-infected samples; BIORAD-SAP missed 4 samples and BIORAD-SG 7 130 
(a further sample gave an uncertain result, but was considered positive in the ROC curve 131 
analyses) (Table 2).  It is of note that the only 2 samples from asymptomatic goats, which 132 
were not recognized by the IDEXX test, were also not detected by 2 two Bio-Rad tests. ROC 133 
curves showed that the sensitivity of the IDEXX was significantly higher only compared to 134 
the BIORAD-SG test (Table 4). Other comparisons did not show any significant differences 135 
(Table 4). 136 
Finally, we compared the sensitivity of rapid tests in recognizing goats with scrapie in the 137 
pre-clinical or clinical phase of disease. While all rapid tests were systematically able to pick 138 
up both natural and experimental scrapie samples from symptomatic goats (Table 3), IDEXX 139 
missed 2 of 24 samples with ‘natural’ scrapie in the pre-clinical phase of disease, BIORAD-140 
SAP missed 4 samples, and BIORAD-SG 7 (Table 3). ROC curves analysis showed that 141 
IDEXX and BIORAD-SAP were significantly more sensitive than BIORAD-SG (Table 4) in 142 
detecting positive samples from pre-clinical animals.  143 
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Several important features of our study should be considered for the surveillance of TSE 144 
diseases in goats. All tests detected 100% of samples from goats with clinical scrapie, 145 
regardless of whether they were experimentally or naturally infected. In contrast, sensitivity 146 
was lower in goats with pre-clinical scrapie and rapid tests missed between 7% (IDEXX) and 147 
24% (BIORAD-SG) of these samples. A second important consideration is that only IDEXX 148 
detected all samples from clinical BSE-infected goats, whereas the other 2 rapid tests missed 149 
between 15% (BIORAD-SG) and 25% (BIORAD-SAP) of samples. These results suggest 150 
that a consistent fraction of pre-clinical scrapie infections are likely missed by the EU 151 
surveillance, mostly in areas where BIORAD tests are in use, and that BSE infection in goats 152 
may also be underreported in areas using the BIORAD rapid tests (Table 2, 4). Assuming that 153 
the same sensitivity on pre-clinical goats would also occur in BSE-infected goats, our data 154 
show that the IDEXX test may detect eventual preclinical field case of BSE infection in goats, 155 
though with a disappointing 7% failure rate. Although the analytical sensitivity of some TSE 156 
rapid tests might be reduced by the method used to prepare our samples16,1, the results raise 157 
some concerns in relation to the current figures on BSE infections in goats deriving from EU 158 
surveillance.  159 
In goats, the difference in performance of rapid tests between scrapie and BSE infection 160 
might depend on the use of proteinase K (PK) digestion, the choice of the primary anti-PrP 161 
antibodies, or both. Interestingly, PK digestion is used by both BIORAD tests but not by 162 
IDEXX and is likely that antibodies used in each kit recognize different PrP epitopes. This 163 
last hypothesis, however, is purely speculative because the details on anti-PrP antibodies are 164 
covered by patents and are therefore not publicly unavailable.  165 
The other interesting result, though based solely on 2 samples, is that only IDEXX and 166 
BIORAD-SAP were able to fully recognize samples from goats with the atypical Nor98 167 
scrapie infection suggesting that the in place surveillance system in countries using the 168 
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BIORAD-SG test would miss a proportion of atypical scrapie infections in the goat 169 
population. The small number of samples, however, is too low to allow a firm conclusion. 170 
All rapid tests in this study failed to recognize the same 2 samples of ‘natural’ preclinical 171 
scrapie. This finding is somewhat of concern because it might indicate that there is a small 172 
subpopulation of ‘naturally’ scrapie-infected goats (e.g. early pre-clinical animals) that would 173 
be missed by all available rapid tests, and thus by the surveillance system. PRNP 174 
polymorphisms might reduce the sensitivity of the assays in goats carrying specific genotypes 175 
by reducing antibody binding epitopes15,4. In our samples, however, statistical analysis did not 176 
show any association between failure of each test and goat genotypes (data not shown). The 177 
reason for this finding remains therefore unknown and might simply depend on low levels of 178 
PrPSc.  179 
Ultimately, none of the three rapid tests picked up any false positives showing a reassuring 180 
100% specificity.  181 
 182 
Sources and manufactures 183 
a.  IDEXX HerdChek ® BSE-scrapie Antigen Test Kit, EIA. IDEXX Laboratories, 184 
Westbrook, ME, USA. 185 
b.  Bio-Rad® TeSeETM SAP Purification-Detection Test Kit, Bio-Rad Laboratories, Marnes-186 
La-Coquette, France. 187 
c. Bio-Rad® TeSeETM Sheep/Goat Purification-Detection Test Kit, Bio-Rad Laboratories, 188 
Marnes-La-Coquette, France. 189 
d.  Prionics® - Check PrioSTRIP SR Prionics AG, Wagistrasse 27A Schlieren-Zürich, CH 190 
8952 Switzerland. 191 
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Tables 267 
Table 1.  Details and origin of goat samples used in the study. 268 
Disease Type 
County of origin 
(Institute°) n 
Classical 
Cyprus 
France 
Greece 
Italy 
Netherlands 
Spain 
UK 
3 
5 
4 
9 
3 
2 
3 
Atypical (Nor98) Italy 2 
Natural scrapie 
TOTAL 31 
Italy (CEA) 5 
France (INRA) 1 Classical 
France (INRA) 6 
Experimental scrapie 
TOTAL 12 
France (INRA) 
Netherlands (CVI) 
1 
6 
France (INRA) 4 
France (INRA) 1 
Netherlands (CVI) 4 
Classical 
Germany (FLI) 
UK (Roslin) 
3 
1 
Experimental BSE 
TOTAL 20 
TOTAL TSE diseases 63 
Negative controls Healthy Italy 35 
 269 
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°INRA, Institut national de la recherche agronomique, France; CVI, Central Veterinary 270 
Institute, The Netherlands; FLI, Friedrich-Loeffler-Institut, Germany; CEA, Centro di 271 
referenza nazionale per lo studio e le ricerche sulle encefalopatie animali e neuropatologie 272 
comparate, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, Turin,  273 
Italy; Roslin, The Roslin Institute, University of Edinburgh, UK. 274 
 275 
 14 
Table 2. Number and percentage of positive samples in goats with different forms of TSE 276 
diseases by different rapid tests  277 
Positive test, n (%) 
Disease Type Inoculum n 
IDEXX BIORAD SG BIORAD SAP 
Classical - 29 27 (93.1) 22° (75.9) 25 (86.2) 
Natural scrapie Atypical 
(Nor98) 
- 2 2 (100) 1 (50.0) 2 (100) 
Experimental 
scrapie 
Classical Scrapie 12 12 (100) 12 (100) 12 (100) 
Experimental 
BSE 
Classical Bovine BSE 20 20 (100) 17 (85.0) 15 (75.0) 
TOTAL TSE 
diseased 
  63 61 (96.8) 52° (82.5) 54 (85.7) 
Negative 
controls 
Healthy - 35 0 (0.0) 0 (0.0) 0 (0.0) 
°One sample gave uncertain result 278 
 15 
Table 3. Number and percentage of positive samples by different tests on ‘natural scrapie’ 279 
affected goats 280 
Positive test, n (%) 
Disease Type 
Clinical 
signs 
n 
IDEXX BIORAD SG BIORAD SAP 
Classical No 22 20 (90.9) 15° (68.2) 18 (81.8) 
Natural scrapie  Atypical 
(Nor98) 
No 2 2 (100) 1 (50) 2 (100) 
TOTAL    24 22 (91.7) 16 (66.6) 20 (83.3) 
Natural scrapie  Classical Yes 7 7 (100) 7 (100) 7 (100) 
Negative 
controls 
Healthy No 35 0 0 0 
°One sample gave uncertain result 281 
 282 
 283 
 284 
 285 
 286 
 287 
 288 
 289 
 290 
 291 
 292 
 293 
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Table 4.  ROC curve analyses294 
 Goats with natural 
and experimental 
TSEs (n= 63) vs. 
controls (n=35) 
Goats with natural 
classical scrapie 
(n=29) vs. controls 
(n=35) 
Goats with 
experimental BSE 
(n=20) vs. controls 
(n=35) 
Goats with 
experimental scrapie 
(n=12) vs. controls 
(n=35) 
Goats with TSE 
with no clinical 
signs (n=24) vs. 
controls (n=35) 
Diagnostic tests AUC (95% CI) AUC (95% CI) AUC (95% CI) AUC (95% CI) AUC (95% CI) 
IDEXX 
0.9841 
(0.96231-1.0000) 
0.9655 
(0.91859-1.0000) 
1.0000 
(1.00000-1.00000) 
1.0000 
(1.00000-1.00000) 
0.9583 
(0.90186-1.0000) 
BIORAD SG 
0.9127 
(0.86545-0.95995) 
0.8793 
(0.8006-0.95856) 
0.9250 (0.84472-
1.00000) 
1.0000 
(1.00000-1.00000) 
0.8333 
(0.73701-0.92966) 
BIORAD SAP 
0.9286 
(0.88502-0.97212) 
0.9310 (0.86717-
0.99490) 
0.8750 
(0.77765-0.97235) 
1.0000 
(1.00000-1.00000) 
0.9167 
(0.84051-0.99282) 
 p value p value p value p value p value 
IDEXX vs. 
BIORAD SG 
0.0013 0.0157 0.0671 = 0.0056 
IDEXX vs. 
BIORAD SAP 
0.0054 0.1498 0.0118 = 0.1482 
BIORAD SG vs. 
BIORAD SAP 
0.5291 0.0723 0.4183 = 0.0320 
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